Methionine: One of the essential amino acids involved in the biochemical formation of several compounds.
N5-CH3-FH4 (5-Methyltetrahydrofolate): A tetrahydrofolate derivative involved in the transfer of one-carbon units in various biosynthetic reactions, particularly in the conversion of homocysteine to methionine.
Vitamin B12: Essential for the conversion of homocysteine to methionine and is also involved in the metabolism of certain amino acids.
Homocysteine: An amino acid produced as a by-product of methionine metabolism.
Serine: An amino acid that contributes to the formation of homocysteine and is involved in various metabolic pathways.
S-adenosylmethionine (SAM): Formed from the condensation of ATP and methionine; acts as a universal methyl donor in numerous methylation reactions.
S-adenosylhomocysteine: The product of methyl transfer reactions mediated by SAM that can be recycled back into homocysteine.
Cystathionine: A compound involved in the transsulfuration pathway linking homocysteine and cysteine.
Cysteine: An amino acid derived from homocysteine that is essential for the synthesis of proteins and various biomolecules.
Threonine: Metabolized to α-ketobutyrate which subsequently leads to succinyl-CoA.
Isoleucine: One of the branched-chain amino acids that degrade into propionyl-CoA, which can contribute to succinyl-CoA formation.
Valine: Another branched-chain amino acid that, along with isoleucine and leucine, leads to the production of acetyl-CoA and propionyl-CoA.
Glucose: Can be converted into propionyl-CoA in different metabolic pathways.
D-methylmalonyl CoA and L-methylmalonyl CoA: Intermediate metabolites formed in the metabolism of certain amino acids that are converted into succinyl-CoA in the presence of Vitamin B12.
Amino Acids Related to Oxaloacetate
Oxaloacetate: A crucial intermediate in the TCA cycle, acting as a substrate for many amino acid syntheses.
Amino acids related to oxaloacetate:
Aspartate: Can be formed through transamination from glutamate and is directly related to the formation of oxaloacetate.
Asparagine: Synthesized from aspartate and glutamine; plays an important role in nitrogen metabolism.
Transamination Reactions:
Catalyzed by PLP (Pyridoxal Phosphate); a cofactor essential for amino acid metabolism involving the transfer of amino groups.
Key reaction involves the formation of aspartate from oxaloacetate and glutamate.
Cysteine Synthesis
Source of sulfur for cysteine synthesis: Derived from the essential amino acid methionine.
SAM (S-adenosylmethionine): Serves as a precursor for numerous methyl transfer reactions, such as the conversion of norepinephrine to epinephrine, indicating its importance in biochemical pathways.
Relationship between Cysteine and Methionine: Cysteine and methionine metabolism is interconnected, emphasizing the importance of sulfur-containing amino acids in biological processes.
Degradation of Branched-Chain Amino Acids
Branched-chain amino acids:
Valine, Isoleucine, Leucine: They can be degraded to form several intermediates, including
α-ketoglutarate, which is converted into glutamate through transamination.
Metabolic Pathways:
The degradation process includes steps such as oxidative decarboxylation and results in the production of various CoA derivatives (e.g., isobutyryl-CoA, α-methylbutyryl-CoA, and isovaleryl-CoA).
Produces energy and essential precursors needed for other metabolic processes similar to fatty acid beta-oxidation.
Maple Syrup Urine Disease (MSUD)
Definition: A genetic disorder characterized by the inability to properly metabolize branched-chain amino acids (valine, leucine, isoleucine).
Enzyme Deficiency: Caused by a deficiency in the enzyme branched-chain α-keto acid dehydrogenase, which leads to the accumulation of these amino acids and their corresponding α-keto acids in the urine.
Clinical Presentation: The accumulation causes a distinctive maple syrup odor in the urine of affected individuals, hence the name of the disease.
Consequences: If untreated, MSUD can lead to severe mental retardation and neurological complications due to toxic levels of branched-chain amino acids.